| 1 |
32180831 | Direct-acting Anticoagulants in Chronic Coronary Syndromes. | 2020 Feb |
1 |
| 2 |
30839367 | Anticoagulation in Acute Coronary Syndrome: Review of Major Therapeutic Advances. | 2019 Mar/Apr |
1 |
| 3 |
29588304 | Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction. | 2018 Mar 27 |
1 |
| 4 |
26995378 | A randomized trial to compare the safety of rivaroxaban vs aspirin in addition to either clopidogrel or ticagrelor in acute coronary syndrome: The design of the GEMINI-ACS-1 phase II study. | 2016 Apr |
1 |
| 5 |
27597298 | [Acute coronary syndrome: Is there a place for direct oral anticoagulants?] | 2016 Oct |
1 |
| 6 |
24861799 | Direct oral anticoagulants in acute coronary syndrome. | 2014 Apr |
1 |
| 7 |
22528328 | Effects on platelet function of a direct acting antagonist of coagulation factor Xa. | 2012 Oct |
1 |
| 8 |
22935021 | Antiplatelet and antithrombin strategies in acute coronary syndrome: state-of-the-art review. | 2012 Aug |
1 |